HUP0302370A2 - Javított, bioaktív savóprotein-hidrolizátum - Google Patents

Javított, bioaktív savóprotein-hidrolizátum

Info

Publication number
HUP0302370A2
HUP0302370A2 HU0302370A HUP0302370A HUP0302370A2 HU P0302370 A2 HUP0302370 A2 HU P0302370A2 HU 0302370 A HU0302370 A HU 0302370A HU P0302370 A HUP0302370 A HU P0302370A HU P0302370 A2 HUP0302370 A2 HU P0302370A2
Authority
HU
Hungary
Prior art keywords
whey protein
protein hydrolysate
wpi
improved bioactive
bioactive whey
Prior art date
Application number
HU0302370A
Other languages
English (en)
Inventor
Alistair Carr
Rachel Lois Fanshawe
Stephanie Adele Harvey
Julian Robert Reid
Ralf-Christian Schlothauer
Linda May Schollum
Original Assignee
New Zealand Dairy Board
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New Zealand Dairy Board filed Critical New Zealand Dairy Board
Publication of HUP0302370A2 publication Critical patent/HUP0302370A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Dairy Products (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A találmány tárgyát eljárás képezi javított ízhatású, funkciójú ésACE-I-inhibitor aktivitású savóprotein-hidrolizátum előállítására WPI-szubsztrátból, az így előállított bioaktív peptidek, alkalmazásuk agyógyászatban, valamint az azokat - önmagukban vagy kombinálva -tartalmazó gyógyászati készítmények, élelmiszertermékek ésnagymértékben szolúubilis WPI-hidrolizátumok. Ó
HU0302370A 2000-09-11 2001-09-11 Javított, bioaktív savóprotein-hidrolizátum HUP0302370A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ506866A NZ506866A (en) 2000-09-11 2000-09-11 Bioactive whey protein hydrolysate free of bitter flavours wherein the enzyme used is a heat labile protease
PCT/NZ2001/000188 WO2002019837A1 (en) 2000-09-11 2001-09-11 Improved bioactive whey protein hydrolysate

Publications (1)

Publication Number Publication Date
HUP0302370A2 true HUP0302370A2 (hu) 2003-10-28

Family

ID=19928101

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0302370A HUP0302370A2 (hu) 2000-09-11 2001-09-11 Javított, bioaktív savóprotein-hidrolizátum

Country Status (19)

Country Link
EP (1) EP1317186B1 (hu)
JP (1) JP2004508025A (hu)
KR (1) KR100845362B1 (hu)
CN (1) CN1229031C (hu)
AT (1) ATE494795T1 (hu)
AU (2) AU9037601A (hu)
BR (1) BR0113812A (hu)
CA (1) CA2421714A1 (hu)
DE (1) DE60143846D1 (hu)
DK (1) DK1317186T3 (hu)
ES (1) ES2359789T3 (hu)
HK (1) HK1063132A1 (hu)
HU (1) HUP0302370A2 (hu)
MX (1) MXPA03002109A (hu)
NO (1) NO326072B1 (hu)
NZ (1) NZ506866A (hu)
PE (1) PE20030289A1 (hu)
WO (1) WO2002019837A1 (hu)
ZA (1) ZA200301982B (hu)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2444215T3 (es) 2002-07-29 2014-02-24 Zymtech Production As Método para la producción de péptidos y aminoácidos a partir de material de origen animal que comprende proteínas
TWI317636B (en) * 2002-11-22 2009-12-01 Meiji Dairies Corp Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress
US7399496B2 (en) * 2003-02-07 2008-07-15 Glanbia Nutritionals (Ireland) Limited Hydrolyzed whey protein compositions
EP1568707A1 (en) * 2004-02-26 2005-08-31 Puleva Biotech, S.A. Antihypertensive peptides from casein hydrolysates
CN100415768C (zh) * 2004-11-29 2008-09-03 中国农业大学 乳清蛋白酶法生产血管紧张素转化酶（ace）抑制肽的方法
EP1907412B1 (en) * 2005-06-30 2012-04-11 Campina Nederland Holding B.V. Peptides inhibiting angiotensin-converting enzyme
AU2007229604A1 (en) * 2006-03-24 2007-10-04 Unilever Plc Healthy food product
US9662368B2 (en) * 2006-06-15 2017-05-30 Murray Goulburn Co-Operative., Limited Formulation comprising whey protein and hydrolysates for improving muscle recovery
EP1967524A1 (en) * 2007-03-06 2008-09-10 Friesland Brands B.V. Methods for producing ACE-inhibitory peptides from whey and peptides obtained thereby
US20090196973A1 (en) * 2008-02-01 2009-08-06 Rich Products Corporation Foam Compositions
DE102008032828A1 (de) * 2008-07-02 2010-01-07 Technische Universität Dresden Tryptophanhaltige Peptide aus alpha-Lactalbumin mit blutdrucksenkender und vasoprotektiver Wirkung für biofunktionelle Lebensmittel
US9055752B2 (en) 2008-11-06 2015-06-16 Intercontinental Great Brands Llc Shelf-stable concentrated dairy liquids and methods of forming thereof
CN101736067B (zh) * 2010-01-08 2012-04-18 中国农业大学 一种乳清蛋白降血压肽及其制备方法与应用
CN101829316B (zh) * 2010-04-30 2012-07-11 中国人民解放军总医院 一种乳清蛋白水解物及其在制备降糖药物中的用途
UA112972C2 (uk) 2010-09-08 2016-11-25 Інтерконтінентал Грейт Брендс ЛЛС Рідкий молочний концентрат з високим вмістом сухих речовин
WO2012075570A1 (en) * 2010-12-09 2012-06-14 Mcgill University Bioactive peptides and proteins containing bioactive peptides, their uses and processes for making the same
JP5892687B2 (ja) * 2011-07-07 2016-03-23 高砂香料工業株式会社 風味改善ペプチド
CN103695518B (zh) * 2013-12-30 2016-04-06 东北农业大学 利用乳清蛋白肽降低血清胆固醇水平的产品和制备方法
US10639334B2 (en) * 2014-01-07 2020-05-05 Mead Johnson Nutrition Company Pediatric nutritional composition with milk peptides for healthy growth and development
CN103805664B (zh) * 2014-03-06 2017-04-05 渤海大学 一种低敏性糖基化乳清蛋白水解物及其制备方法
WO2015169928A1 (en) * 2014-05-07 2015-11-12 Nestec S.A. Foamable dairy product
JP6022738B2 (ja) * 2014-06-16 2016-11-09 キリン株式会社 記憶学習機能及び／又は認知機能を増強するための組成物
JP6262694B2 (ja) * 2014-08-18 2018-01-17 森永乳業株式会社 プロリルオリゴペプチダーゼ阻害剤
ES2837050T3 (es) 2015-10-01 2021-06-29 Frieslandcampina Nederland Bv Composición nutricional líquida que comprende caseína micelar y proteína de suero de leche hidrolizada
CN108137650B (zh) * 2015-11-16 2022-04-08 麒麟控股株式会社 肽组合物及其制造方法
BR112018010672B1 (pt) 2015-12-18 2022-05-10 Société des Produits Nestlé S.A. Composições líquidas esterilizadas por calor com alto teor de proteína, seu processo contínuo de preparação, uso de proteína hidrolisada, e método para controlar a viscosidade e evitar o gosto amargo das ditas composições
CN107136295B (zh) * 2016-03-01 2021-07-27 内蒙古伊利实业集团股份有限公司 一种部分水解乳清蛋白粉及其制备方法
CN107814836A (zh) * 2017-12-01 2018-03-20 浙江熊猫乳业集团股份有限公司 一种生物活性多肽fpgpipns及其制备方法和应用
CN107858394B (zh) * 2017-12-25 2021-09-07 内蒙古蒙牛乳业（集团）股份有限公司 乳清蛋白水解产物的制备方法
ES2964808T3 (es) 2019-05-29 2024-04-09 Arla Foods Amba Hidrolizados de proteína de suero de la leche extensamente hidrolizados apetecibles
CN113061175B (zh) * 2020-12-17 2023-04-21 西北民族大学 以曲拉为原料制备的钙共沉淀蛋白及其制备方法
CN114457137B (zh) * 2022-01-12 2024-05-24 广州舜康生物科技有限公司 一种连续循环水解并精准筛选肽分子量的深度水解乳清蛋白的制备方法
CN115669945B (zh) * 2022-10-24 2024-03-08 上海艾斯顿医疗科技有限公司 一种具有神经营养作用的脂质体包裹多肽及制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK589785A (da) * 1985-12-18 1987-06-19 Samuelsson Ernst Gunnar Peptidpraeparat, fremgangsmaade til fremstilling deraf samt anvendelse af peptidpraeparatet
SE459140B (sv) * 1986-11-25 1989-06-12 Albuglobe Ab Hydrolys av vassleprotein foer att underlaetta avskiljning av fett daerifraan
DK0518999T3 (da) * 1990-03-09 1995-12-18 Novo Nordisk As Proteinhydrolysater
KR100237147B1 (ko) * 1991-05-31 2000-01-15 버크백 플레밍 유장 단백질 가수분해물의 제조방법
WO1993004593A1 (en) * 1991-08-30 1993-03-18 Teagasc, The Agriculture And Food Development Authority Hypoallergenic whey protein hydrolysate
DK71292D0 (hu) * 1992-05-27 1992-05-27 Novo Nordisk As
JP3059595B2 (ja) * 1992-11-20 2000-07-04 森永乳業株式会社 沈澱を生じない乳清蛋白質分解物の製造法
WO1996011584A1 (fr) * 1994-10-14 1996-04-25 Morinaga Milk Industry Co., Ltd. Melange de peptides et leurs produits_________________
EP0871371B1 (en) * 1995-06-30 2004-03-03 Arla Foods amba A method of producing a peptide mixture
JPH1033115A (ja) * 1996-07-24 1998-02-10 Nouchikusangiyou Shinko Jigyodan ホエー飲料とその製造法
DE69920219T2 (de) * 1998-06-17 2005-09-22 New Zealand Dairy Board Bioaktive molke-eiweisshydrolysate
MY129566A (en) * 1999-01-19 2007-04-30 Nestle Sa A hypoallergenic composition containing tolerogenic peptides inducing oral tolerance

Also Published As

Publication number Publication date
NO20031096L (no) 2003-05-07
CN1229031C (zh) 2005-11-30
DK1317186T3 (da) 2011-05-02
HK1063132A1 (en) 2004-12-17
JP2004508025A (ja) 2004-03-18
MXPA03002109A (es) 2004-05-24
EP1317186B1 (en) 2011-01-12
KR20030046442A (ko) 2003-06-12
DE60143846D1 (de) 2011-02-24
NZ506866A (en) 2003-05-30
PE20030289A1 (es) 2003-03-25
BR0113812A (pt) 2005-02-01
ES2359789T3 (es) 2011-05-26
CN1474656A (zh) 2004-02-11
AU9037601A (en) 2002-03-22
NO326072B1 (no) 2008-09-15
CA2421714A1 (en) 2002-03-14
ZA200301982B (en) 2004-06-25
WO2002019837A1 (en) 2002-03-14
AU2001290376B2 (en) 2005-08-25
EP1317186A4 (en) 2006-04-19
ATE494795T1 (de) 2011-01-15
EP1317186A1 (en) 2003-06-11
KR100845362B1 (ko) 2008-07-09
NO20031096D0 (no) 2003-03-10

Similar Documents

Publication Publication Date Title
HUP0302370A2 (hu) Javított, bioaktív savóprotein-hidrolizátum
Tsai et al. The inhibitory effects of freshwater clam (Corbicula fluminea, Muller) muscle protein hydrolysates on angiotensin I converting enzyme
Segura Campos et al. Angiotensin I-converting enzyme inhibitory peptides of chia (Salvia hispanica) produced by enzymatic hydrolysis
ATE442855T1 (de) Biologisch nicht-abbaubares peptid, inhibitor des angiotensinumwandelnden enzyms, arzneimittel und funktionelles nahrungsmittel
CY1108049T1 (el) Πεπτιδια με βαση την αλληλουχια της ανθρωπινης λακτοφερρινης και χρηση τους
HUP0203256A2 (hu) Eljárás magas vérnyomás elleni tripeptideket tartalmazó készítmény előállítására
PT1227736E (pt) Hidrolisados de proteinas produzidas com a utilizacao de proteases marinhas
WO2002044320A3 (en) Human elongase genes and uses thereof
AU2003260286A1 (en) Collectin-complement activating protein chimeras
NO20042188L (no) Hydrolysert marint proteinprodukt og et fôrprodukt omfattende dette, fremgangsmate for fremstilling og anvendelse
Iwaniak et al. Proteins as the source of physiologically and functionally active peptides
DK1383397T3 (da) Aromakoncentrater
HUP0100410A2 (hu) Fagyásgátló proteinek és ezeket tartalmazó élelmiszerek
AU2003207417A1 (en) Use of tryptophan rich peptides
AU6228300A (en) Modification of foaming properties of proteins
MXPA06002648A (es) Fracciones de leche y preparaciones de leche para el tratamiento y/o prevencion de las enfermedades medidas por cox-2.
Wei et al. Coupled neutrase–catalyzed plastein reaction mediated the ACE-inhibitory activity In Vitro of casein hydrolysates prepared by Alcalase
WO2003044047A3 (en) Virulence proteins of the genus yersinia and uses thereof
WO2001064899A8 (de) Nukleotidsequenzen kodierend für proteine beteiligt an der biosynthese von l-serin, verbessertes verfahren zur mikrobiellen herstellung von l-serin sowie ein dazu geeigneter genetisch veränderter mikroorganismus
JP2002541120A (ja) 血液細胞の増殖阻害用及び自動免疫疾患の治療用カスパーゼ阻害剤
WO2004000870A3 (en) Two synthetic peptides for treatment and prevention of cancers
Hall Fighting phobias.
EP1201679A3 (en) Angiotensin I-converting enzyme inhibitory substance
DE602004022453D1 (de) Peptide mit ace-hemmwirkung
WO2002100897A3 (fr) Complexes moleculaires brca1/acc alpha, applications diagnostiques et therapeutiques